reboxetine has been researched along with Enuresis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lundmark, E; Nevéus, T | 1 |
| Laor, N; Lerer-Amisar, D; Ratner, S; Toren, P; Weizman, A | 1 |
| Nevéus, T | 1 |
1 trial(s) available for reboxetine and Enuresis
| Article | Year |
|---|---|
A possible antienuretic effect of reboxetine in children and adolescents with attention deficit/hyperactivity disorder: case series.
Topics: Adolescent; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Child; Enuresis; Female; Humans; Male; Morpholines; Reboxetine; Time Factors; Treatment Outcome | 2005 |
2 other study(ies) available for reboxetine and Enuresis
| Article | Year |
|---|---|
Reboxetine in therapy-resistant enuresis: a retrospective evaluation.
Topics: Administration, Oral; Adolescent; Adrenergic Uptake Inhibitors; Antidiuretic Agents; Child; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Drug Resistance; Enuresis; Female; Follow-Up Studies; Humans; Imipramine; Male; Morpholines; Pilot Projects; Prognosis; Reboxetine; Retrospective Studies; Urination; Young Adult | 2009 |
Reboxetine in therapy-resistant enuresis: results and pathogenetic implications.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Child; Cohort Studies; Congenital Abnormalities; Deamino Arginine Vasopressin; Disabled Children; Dose-Response Relationship, Drug; Drug Administration Schedule; Enuresis; Female; Follow-Up Studies; Humans; Imipramine; Male; Morpholines; Probability; Prospective Studies; Quality of Life; Reboxetine; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2006 |